Praise For The U.S. HIV Program That Trump Wants To Cut : Goats and Soda PEPFAR, the massive U.S. program that primarily battles HIV in Africa, turns 15 this year. And researchers say it has had an incredible impact.

Aid

Praise For The Global HIV Program That Trump Wants To Cut

  • Download
  • <iframe src="https://www.npr.org/player/embed/632395250/632771966" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

AUDIE CORNISH, HOST:

Research presented at an international AIDS conference in Amsterdam this week portrays one U.S. government program as a success story. The initiative is known as PEPFAR, the President's Emergency Plan for AIDS Relief. It's a multibillion-dollar program, and the Trump administration has it slated for cuts. But this research, says PEPFAR, has helped bring the AIDS epidemic under control in many parts of the world. NPR's Jason Beaubien reports.

JASON BEAUBIEN, BYLINE: Bernard Haufiku is the current health minister for Namibia. He says that for his small Southern African nation, AIDS has been more than just a disease.

BERNARD HAUFIKU: Apart from the actual human life that had been lost, it eroded our economy basically. It invaded our own actual social fabric. Now we're spending on health so much that we could have spent on other development project.

BEAUBIEN: Despite 12 to 14 percent of all adults in Namibia being HIV positive, the country now says it's on target to meet ambitious U.N. goals to eliminate AIDS as a public health threat by 2030. A study released at the conference shows that over the last two years, the number of new HIV infections in Namibia dropped by 40 percent. Haufiku says Namibia has done this by focusing on hotspots of transmission, identifying who's infected and getting them on treatment.

HAUFIKU: And as you know that when you put people on treatment, you basically are reducing the risk of transmission from the next person.

BEAUBIEN: Namibia has a tiny population of 2 1/2 million people. It has limited resources. Last year, the country got $73 million in funding from PEPFAR. Haufiku says the strides Namibia and other African nations have made against HIV would not have been possible without PEPFAR.

HAUFIKU: PEPFAR, which is basically U.S. taxpayers' money, has made a huge difference as a matter of life and death, actually, in many, many African countries.

BEAUBIEN: President George W. Bush launched PEPFAR in 2003 as an emergency measure. It's since grown into the largest source of U.S. funding to combat HIV globally. Another study released at the AIDS conference looks at whether PEPFAR spending in Kenya reduced the transmission of HIV from pregnant mothers to their babies and led to a drop in infant mortality. Donna Spiegelman, a professor of biostatistics at Yale, is one of the co-authors of the Kenya report. Over the course of a decade, nearly a quarter of a billion dollars flowed into Kenya through PEPFAR.

DONNA SPIEGELMAN: It is a major investment of the U.S. government. I think - I feel as a statistician and as a public health professional it's really important to be sure that the dollars we're spending across a range of public health programs are being spent wisely.

BEAUBIEN: During the time period she was looking at from 2004 to 2014, infant mortality went down nationwide in Kenya. But Spiegelman's team found that in the provinces with the most PEPFAR funding, infant mortality was as much as 30 percent lower than in the provinces that got the least amount of money from the program. Not only were deaths prevented, tens of thousands of babies were born free of HIV even though their mothers were carrying the virus.

SPIEGELMAN: So we're happy to contribute to showing that in this particular case, it seems as if the investment was well worth it.

BEAUBIEN: The Trump administration wants to slash nearly a billion dollars out of PEPFAR's $4 1/2 billion annual budget. The administration says it wants to streamline the program and rather than fund HIV/AIDS programs globally to focus on 13 countries that are close to getting the disease under control. So far, however, Congress has resisted those cuts. Jason Beaubien, NPR News.

Copyright © 2018 NPR. All rights reserved. Visit our website terms of use and permissions pages at www.npr.org for further information.

NPR transcripts are created on a rush deadline by Verb8tm, Inc., an NPR contractor, and produced using a proprietary transcription process developed with NPR. This text may not be in its final form and may be updated or revised in the future. Accuracy and availability may vary. The authoritative record of NPR’s programming is the audio record.